| 名称 | VH032-PEG5-C6-Cl |
| 描述 | VH032-PEG5-C6-Cl (HaloPROTAC 2) is a small molecule HaloPROTAC that incorporates the VH032 based VHL ligand and 5-unit PEG linker. VH032-PEG5-C6-Cl is capable of inducing the degradation of GFP-HaloTag7 in cell-based assays[1]. |
| 体外活性 | Treatment (24 hour) with VH032-PEG5-C6-Cl leads to nearly 70% degradation of GFP-Halotag7 at 2.5 μM[1]. |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | DMSO : 50 mg/mL (63.82 mM), Sonication is recommended. |
| 关键字 | VHL | VH032-PEG5-C6-Cl | VH-032-PEG5-C6-Cl | VH032PEG5C6Cl | VH032 PEG5 C6 Cl |
| 相关产品 | Pomalidomide-PEG4-C-COOH | Pomalidomide 4'-PEG3-azide | Thalidomide-O-amido-PEG2-C2-NH2 TFA | Pomalidomide 4'-alkylC3-acid | (S,R,S)-AHPC-PEG3-N3 | Pomalidomide-PEG2-CO2H | Pomalidomide-PEG3-CO2H | Thalidomide-PEG4-Propargyl | Thalidomide-NH-CH2-COOH | Pomalidomide-PEG4-Ph-NH2 | (S,R,S)-AHPC-C4-NH2 hydrochloride | (S,R,S)-AHPC-PEG3-NH2 hydrochloride |
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断、治疗或实验，不可药用，不可食用。
Copyright© 2022-2026 上海捷世凯生物科技有限公司 版权所有，All Rights Reserved 沪ICP备2022023965号
沪公网安备 31012002005937 
许可证编号：沪（奉）应急管危经许[2025]203724
主管 朱如燕 13795461237
售后 全香 15901740225
微信公众号
